One of the most important postharvest plant pathogens that affect strawberries, grapes and tomatoes is Botrytis cinerea, known as gray mold. The fungus remains in latent form until spore germination conditions are good, making infection control difficult, causing great losses in the whole production chain. This study aimed to purify and identify phenazine-1-carboxylic acid (PCA) produced by the Pseudomonas aeruginosa LV strain and to determine its antifungal activity against B. cinerea. The compounds produced were extracted with dichloromethane and passed through a chromatographic process. The purity level of PCA was determined by reversed-phase high-performance liquid chromatography semi-preparative. The structure of PCA was confirmed by nuclear magnetic resonance and electrospray ionization mass spectrometry. Antifungal activity was determined by the dry paper disc and minimum inhibitory concentration (MIC) methods and identified by scanning electron microscopy and confocal microscopy. The results showed that PCA inhibited mycelial growth, where MIC was 25 µg mL-1. Microscopic analysis revealed a reduction in exopolysaccharide (EPS) formation, showing distorted and damaged hyphae of B. cinerea. The results suggested that PCA has a high potential in the control of B. cinerea and inhibition of EPS (important virulence factor). This natural compound is a potential alternative to postharvest control of gray mold disease.

Citrus canker is a lot destructive disease of citrus species. The challenge is to find new compounds that show strong antibiotic activity, low toxicity to plants and the environment. The objectives of the present study are (1) produce, purify and evaluate the antibiotic activity of secondary metabolites produced by induction by P. aeruginosa LV strain in vitro against Xanthomonas citri subsp. citri (strain 306), (2) study the potential for semi-purified secondary metabolites on foliar application to control citrus canker under greenhouse conditions, (3) identify the antibiotic activity in orange leaf mesophyll infected with strain 306 by electron microscopy. Two pure bioactive compounds were isolated, organocopper antibiotic compound and phenazine-1-carboxamide. The phenazine-1-carboxamide did not show any antibiotic activity under the experimental conditions used in this study. The organocopper antibiotic compound showed a high level of antibiotic activity with a minimum inhibitory concentration of 0.12 µg mL-1. In greenhouse tests for control of citrus canker in orange trees, the semi-purified fraction F3d, reduced lesion formation about 97%. The concentration used was five hundred times lower than recommended commercial product of metallic copper-based. Electron microscopy showed that F3d altered the exopolysaccharide matrix and causing cell lysis of the pathogen inside the citrus canker lesions. These results suggest that secondary metabolites produced by induction by P. aeruginosa LV strain has a high potential to be used as a bioproduct to control citrus canker.

The increasing emergence of multidrug-resistant (MDR) organisms in hospital infections is causing a global public health crisis. The development of drugs with effective antibiotic action against such agents is of the highest priority. In the present study, the action of Fluopsin C against MDR clinical isolates was evaluated under in vitro and in vivo conditions. Fluopsin C was produced in cell suspension culture of Pseudomonas aeruginosa LV strain, purified by liquid adsorption chromatography and identified by mass spectrometric analysis. Bioactivity, bacterial resistance development risk against clinically important pathogenic strains and toxicity in mammalian cell were initially determined by in vitro models. In vivo toxicity was evaluated in Tenebrio molitor larvae and mice. The therapeutic efficacy of intravenous Fluopsin C administration was evaluated in a murine model of Klebsiella pneumoniae (KPC) acute sepsis, using six different treatments. The in vitro results indicated MIC and MBC below 2 μg/mL and low bacterial resistance development frequency. Electron microscopy showed that Fluopsin C may have altered the exopolysaccharide matrix and caused disruption of the cell wall of MDR bacteria. Best therapeutic results were achieved in mice treated with a single dose of 2 mg/kg and in mice treated with two doses of 1 mg/kg, 8 h apart. Furthermore, acute and chronic histopathological studies demonstrated absent nephrotoxicity and moderate hepatotoxicity. The results demonstrated the efficacy of Fluopsin C against MDR organisms in in vitro and in vivo models, and hence it can be a novel therapeutic agent for the control of severe MDR infections.

This study evaluated the antibiotic activity and induction of resistance in plants by compounds produced by Pseudomonas aeruginosa LV strain on the control of bacterial stem rot in tomato. Compounds were extracted from the cell-free supernatant of a bacterial culture and purified. The F4A fraction was composed of two major compounds, an antibiotic and a phenazine (PCN). The first experiment evaluated the antibiotic activity of F4A, and the second one compared the ability of F4A and PCN to elicit systemic acquired resistance (SAR). In both experiments, plants were infected with Pectobacterium carotovorum subsp. carotovorum (Pcc). The minimum inhibitory concentration of F4A was 7.81 μg mL⁻¹, and PCN did not inhibit bacterial growth. The results suggest that F4A has antibiotic activity. Scanning electron microscopy revealed changes in bacterial cells after 3 h treatment with F4A. F4A and PCN decreased symptoms of stem rot and increased fruit production. Plant response was estimated by determination of peroxidase, polyphenol oxidase, and phenylalanine ammonia lyase activity. Plants treated with PCN or F4A showed greater enzyme activity than plants that were not treated or treated with Bion®, suggesting that PCN increased SAR. The compounds showed the potential to control Pcc in vitro and in vivo and to induce plant response.

The bacterial resistance for antibiotics is one of the most important problems in public health and only a small number of new products are in development. Antagonistic microorganisms from soil are a promising source of new candidate molecules. Products of secondary metabolism confer adaptive advantages for their producer, in the competition for nutrients in the microbial community. The biosynthesis process of compounds with antibiotic activity is the key to optimize their production and the transcriptomic study of microorganisms is of great benefit for the discovery of these metabolic pathways. Pseudomonas aeruginosa LV strain growing in the presence of copper chloride produces a bioactive organometallic compound, which has a potent antimicrobial activity against various microorganisms. The objective of this study was to verify overexpressed genes and evaluate their relation to the organometallic biosynthesis in this microorganism. P. aeruginosa LV strain was cultured in presence and absence of copper chloride. Two methods were used for transcriptomic analysis, genome reference-guided assembly and de novo assembly. The genome referenced analysis identified nine upregulated genes when bacteria were exposed to copper chloride, while the De Novo Assembly identified twelve upregulated genes. Nineteen genes can be related to an increased microbial metabolism for the extrusion process of exceeding intracellular copper. Two important genes are related to the biosynthesis of phenazine and tetrapyrroles compounds, which can be involved in the bioremediation of intracellular copper and biosynthesis of the organometallic compound. Additional studies are being carried out to further prove the function of the described genes and relate them to the biosynthetic pathway of the organometallic compound.